A strategy of early rhythm control for atrial fibrillation (AF), compared with a rate-control approach, led to a reduction in risk for a composite cardiovascular (CV) endpoint over 5 years, whether ...
March 5, 2004 — The results of a substudy from the Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) trial find that patients with persistent atrial fibrillation ...
Previously, patients with advanced atrial fibrillation (AF/AFib) had limited treatment choices. Since February 2024, West ...
In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line ...
Recurrent arrhythmia, where irregular heart rhythms return even after treatment, can present challenges and increase the risk of complications, but can be managed with a cardiologist’s help and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results